Howdy traders, it’s Bryce here.
The hottest opportunities for small account traders are still biotech spikers.
We spoke about it over the weekend … And on Monday the market gave us a new runner.
We don’t buy and hold these plays.
The volatility is intense: Today’s runner spiked 220%.
But the spikes don’t last forever. That’s why we’re not investing. Instead, we react to key price action when it fits our patterns.
The patterns help us determine when to get in and when to get out. As a result, most of the time I sit in cash. My account isn’t exposed to the market unless I see a perfect setup.
That’s how I grew my account past $1 million. One trade at a time with the most popular trading patterns.
And there are 2 biotech stocks right now that look like they’re ready to pop.
I cover all the details in today’s post.
Keep reading …
First and foremost, I’m still interested in Vivos Therapeutics Inc. (NASDAQ: VVOS).
The price spiked 1,000% on November 29 after the company announced an FDA approval for its sleep apnea treatment.
FDA approval is big news in the stock market world. Especially for tiny penny stocks like VVOS.
And even though the price dipped substantially off the highs, I still think there’s potential for a follow-up bounce.
- The float is still low: 1 million shares.
- A low supply of shares helps the price spike higher when demand increases.
- The price is consolidating near key support.
- Price consolidation can hint at stock rallies in the future.
Take a look at a chart of VVOS and pay attention to the $16 level.
Prices hovered at that level on the first day of the spike. And right now the price is consolidating around that level again.
Watch for bullish volatility in the next few days.
The second biotech stock I’m watching is Alterity Therapeutics Limited (NASDAQ: ATHE).
It spiked on Monday, December 4 after announcing positive efficacy data from a Parkinson’s study. The move reached 220% and consolidated into the close.
Plus, the float is only 3.9 million shares.
We could see some fireworks on Tuesday.
But the biggest move today could come from a different stock entirely.
Some of the biggest spikers are the stocks that announce news in premarket.
That’s how I found the 220% ATHE runner.
But most people don’t have time to run a scan and sift through news in the morning. Thankfully, we don’t have to do that anymore.
Artificial intelligence is evolving the way we trade stocks. And by “we” I mean “small-account traders”.
Millionaire trader and my mentor, Tim Sykes, recently developed a process to incorporate AI. And it drastically reduces a trader’s preparation time.
Don’t leave your account up to chance.
The AI does all the heavy lifting. Then I decide whether I’d like to make the trade.
Stop wasting time, red-hot runners are spiking RIGHT NOW.